Chargement en cours...
Update on systemic therapy for colorectal cancer: biologics take sides
Over the last decade, progress in the management of metastatic colorectal cancer (CRC) has focused on the development of biologic therapy in addition to the back bone of combination chemotherapy. Anti-epidermal growth factor receptor (EGFR) antibodies and agents targeting angiogenesis are widely use...
Enregistré dans:
| Publié dans: | Transl Gastroenterol Hepatol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6414333/ https://ncbi.nlm.nih.gov/pubmed/30976712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2019.01.12 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|